GW501516 10 (Cardarine)

Descrizione

Nome del prodotto: GW501516 10 (Cardarine)

Descrizione:

GW501516 10 (Cardarine) is a well-known SARM (Selective Androgen Receptor Modulator) that is hugely popular among those seeking effective weight loss and performance improvement. It’s widely appreciated for its prominent benefits regarding fat loss, endurance, muscle growth, and cardiovascular performance. Essentially, Cardarine gives users the capability to exert themselves to the maximum without the accompanying side effects associated with using hormonal products.

Benefici:

• Enhanced Endurance and Cardiovascular Performance
• Assists with Effective Weight Loss
• Promotion of Minimal Muscle Growth
• Support for other Anabolic Compounds.
• Reduction of Bad Cholesterol Levels
• Prevention of Oxidative Stress on Blood Vessels
• Reduced Kidney Inflammation

Manufacturing Details:

This product is manufactured by Deus Medical – a company recognized for eschewing reselling of repackaged powders from China. They produce all their products within high-standard pharmaceutical facilities based in India. All Deus products undergo stringent testing and are certified by European third parties before they’re eligible for distribution in Europe.

Confezione:

The product is available in a tablet form that is both practical and convenient, sealed in easy-to-use blister packs.

Dosaggio:

For optimal results, it is advisable to take 2 tablets a day. One tablet should be taken before the commencement of your training regime.

As with any supplement or medication, you should consult your doctor or a qualified healthcare provider before starting any new medications or supplements. Always follow the manufacturer’s dosage recommendations and never exceed the prescribed dosage.

1. PPARδ agonist GW501516. (2008). Cell Metabolism, 8(3), 212–213. doi:10.1016/j.cmet.2008.08.007
2. Shearer, B.G., & Billin, A.N. (2007). The next generation of PPAR drugs: do we have the tools to find them? Biochimica et Biophysica Acta (BBA) – Molecular and Cell Biology of Lipids, 1771(8), 1082–1093. doi:10.1016/j.bbalip.2007.03.006
3. Sprecher, D. L., et al. (2007). Triglyceride: high-density lipoprotein cholesterol effects in healthy subjects administered a peroxisome proliferator activated receptor δ agonist. Arteriosclerosis, Thrombosis, and Vascular Biology, 27(2), 359–365. doi:10.1161/01.ATV.0000254681.78662.48
4. Oliver, W. R., et al. (2001). A selective peroxisome proliferator-activated receptor δ agonist promotes reverse cholesterol transport. Proceedings of the National Academy of Sciences, 98(9), 5306–5311. doi:10.1073/pnas.091021198
5. Kang, K., et al. (2008). Peroxisome proliferator-activated receptor-δ (PPARδ)-mediated regulation of preadipocyte proliferation and gene expression is dependent on cAMP signaling. Rivista di chimica biologica, 283(6), 3244–3253. doi:10.1074/jbc.M706981200
6. Tanaka, T., et al. (2003). Activation of per